Eli Lilly, a major pharmaceutical company, is spending $2.8 billion to acquire AtaiBeckley, a biopharmaceutical company working on new treatments […]
A new cancer prevention therapy called NOUS-209 will be discussed at the European Society for Medical Oncology Congress in 2026.
Mission Therapeutics, a biotechnology company based in Cambridge, has agreed to sell its kidney drug MTX652 to Dimerix Limited, an
R1 Therapeutics has started a global phase 2b clinical trial for a new medication called AP306, designed to treat high
The European Pharmacopoeia Commission has published an updated chapter (5.1.6) on alternative microbiological testing methods, making it easier for professionals
Scientists have made progress in developing a dissolvable microneedle patch that could store and deliver mRNA vaccines without the need
Eisai and Biogen, two pharmaceutical companies, have received approval from the U.S. Food and Drug Administration (FDA) for a new
Scientists have discovered that a genetically engineered version of a common gut bacteria, called Bifidobacterium longum, could help boost the
AstraZeneca, a major pharmaceutical company, has made a significant agreement with Dizal Pharmaceutical, a Chinese drug developer, to gain worldwide
EpilepsyGTx, a company working on new treatments for epilepsy, has teamed up with ClearPoint Neuro to use a specialized tool